NCT06368414
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- Gachon University Gil Medical Center Incheon, South Korea
Clinical trial condition
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.
310 public trials
16 recruiting studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results
Recruiting
Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia
NCT06082804
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
- Locations
-
- Centre Hospitalier d'Avignon, Hôpital Henri Duffaut Avignon, France
NCT07362225
- Conditions
- Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
- Locations
-
- MPN Research Foundation Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT01137643
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +98 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT06119269
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- University of Cagliari - Businco Hospital - Unit of Hematology and Bone Marrow Transplant Cagliari, Italy
- Policlinico Milano Milan, Italy
- University of Naples Federico II - Unit of Hematology Naples, Italy
- Santa Chiara University Hospital Pisa, Italy
NCT05367700
- Conditions
- Bone Marrow Diseases, CML, Accelerated Phase, CML, Chronic Phase, +14 more
- Locations
-
- Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
Active, not recruiting
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
NCT05007873
- Conditions
- BCR-ABL1 Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia, Bone Marrow Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
NCT02530034
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
- Locations
-
- Augusta University Augusta, Georgia, United States
- Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
Active, not recruiting
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
NCT03516279
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, not recruiting
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
NCT03722420
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- Peking University People's Hospital(北京大学人民医院) Beijing, China